Fighting cancer together

Learn how Chief Information Officer Jim Graham has gotten involved in the fight against cancer and why a career at Prime/Magellan Rx is a perfect fit for him.

November 9, 2023

Like many people across the world, I have been personally touched by cancer.

My mother, father and sister all survived cancer diagnoses, while three of my grandparents and my wife’s mother passed away from the disease.

I have directly seen the horrific impacts of cancer and it has left a lasting imprint on me, changing how I think and reminding me not to take life for granted.

This is one reason I came to Prime 10 years ago. I am driven by the opportunity to live out Prime/Magellan Rx’s purpose to reimagine pharmacy and recognize the role we play in helping people live longer and healthier lives.

One way we do this is through our revolutionary IntegratedRx® program, a model of care that can improve patient outcomes, reduce costs and improve patient satisfaction. IntegratedRx – Oncology is a medically integrated dispensing (MID) model of care , meaning patients don’t have to worry about going to a separate pharmacy for their oral anticancer drugs, they can get their medicine onsite at the oncology clinic. It’s a one-stop solution for cancer care, designed to take away some of the complexities that come along with the journey.

It’s initiatives like these that make a difference in cancer care and make me proud to work at Prime/Magellan Rx. We truly prioritize innovation and member-centric solutions so we can provide the same level of care we would want for our loved ones.

Outside of my work at Prime/Magellan Rx, I’ve sought out opportunities to get involved with nonprofit organizations that fight cancer. Recently, I participated in a virtual auction with CIOs Against Cancer, which benefits American Cancer Society early-stage cancer research projects. Together with other CIOs, we raised $250,000 at the event.

Personally, this event hit home and professionally it’s in line with our innovative work at Prime/Magellan Rx, as we can reshape the landscape of disease diagnosis, progression and treatment for our members. It was a great way to get involved.

Cancer impacts people from many different backgrounds and knows no boundaries. It’s a shared challenge that has touched many of us. I’m happy to do my part, both professionally and personally, to help extinguish this disease.

Related news


May 20, 2024

Preventing opioid overdoses with naloxone

As prescription opioid overdoses rise in the U.S., the Prime/MRx Special Investigations Unit (SIU) shares how to identify if someone has overdosed and how you can help save a life


May 15, 2024

High-Cost Therapy Profile

Detailed information about Fidanacogene elaparvovec-dzkt Intravenous (IV)


May 15, 2024

June 2024 decisions expected from the FDA

Your monthly synopsis of new drugs expected to hit the market